{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:25:08Z","timestamp":1792603508786,"version":"4.5.0"},"reference-count":102,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Antimicrobials have allowed medical advancements over several decades. However, the continuous emergence of antimicrobial resistance restricts efficacy in treating infectious diseases. In this context, the drug repositioning of already known biological active compounds to antimicrobials could represent a useful strategy. In 2002 and 2003, the SARS-CoV pandemic immobilized the Far East regions. However, the drug discovery attempts to study the virus have stopped after the crisis declined. Today\u2019s COVID-19 pandemic could probably have been avoided if those efforts against SARS-CoV had continued. Recently, a new coronavirus variant was identified in the UK. Because of this, the search for safe and potent antimicrobials and antivirals is urgent. Apart from antiviral treatment for severe cases of COVID-19, many patients with mild disease without pneumonia or moderate disease with pneumonia have received different classes of antibiotics. Diarylureas are tyrosine kinase inhibitors well known in the art as anticancer agents, which might be useful tools for a reposition as antimicrobials. The first to come onto the market as anticancer was sorafenib, followed by some other active molecules. For this interesting class of organic compounds antimicrobial, antiviral, antithrombotic, antimalarial, and anti-inflammatory properties have been reported in the literature. These numerous properties make these compounds interesting for a new possible pandemic considering that, as well as for other viral infections also for CoVID-19, a multitarget therapeutic strategy could be favorable. This review is meant to be an overview on diarylureas, focusing on their biological activities, not dwelling on the already known antitumor activity. Quite a lot of papers present in the literature underline and highlight the importance of these molecules as versatile scaffolds for the development of new and promising antimicrobials and multitarget agents against new pandemic events.<\/jats:p>","DOI":"10.3390\/antibiotics10010092","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T11:39:55Z","timestamp":1611056395000},"page":"92","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7420-4706","authenticated-orcid":false,"given":"Alessia","family":"Catalano","sequence":"first","affiliation":[{"name":"Department of Pharmacy-Drug Sciences, University of Bari Aldo Moro, 70126 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5179-7118","authenticated-orcid":false,"given":"Domenico","family":"Iacopetta","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Pellegrino","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8417-2103","authenticated-orcid":false,"given":"Stefano","family":"Aquaro","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Franchini","sequence":"additional","affiliation":[{"name":"Department of Pharmacy-Drug Sciences, University of Bari Aldo Moro, 70126 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2435-8931","authenticated-orcid":false,"given":"Maria Stefania","family":"Sinicropi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2020). Tackling Antimicrobial Resistance, WHO. Eurohealth (Lond)."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: Progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_3","unstructured":"Nascimento, I.J.D.S., de Aquino, T.M., and da Silva-J\u00fanior, E.F. (2020). Drug repurposing: A strategy for discovering inhibitors against emerging viral infections. Curr. Med. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1016\/j.vaccine.2017.04.082","article-title":"Aids, Avian flu, SARS, MERS, Ebola, Zika\u2026 What next?","volume":"35","author":"Reperant","year":"2017","journal-title":"Vaccine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/tmi.13383","article-title":"The COVID-19 epidemic","volume":"25","author":"Velavan","year":"2020","journal-title":"Trop. Med. Int. Health"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/joim.13091","article-title":"COVID-19 diagnosis and management: A comprehensive review","volume":"288","author":"Pascarella","year":"2020","journal-title":"J. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"0300060520949077","DOI":"10.1177\/0300060520949077","article-title":"Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2","volume":"48","author":"Fadaka","year":"2020","journal-title":"J. Intern. Med. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"m4857","DOI":"10.1136\/bmj.m4857","article-title":"Covid-19: New coronavirus variant is identified in UK","volume":"371","author":"Wise","year":"2020","journal-title":"BMJ"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10735-020-09915-3","article-title":"COVID-19 and multiorgan failure: A narrative review on potential mechanisms","volume":"51","author":"Mokhtari","year":"2020","journal-title":"J. Mol. Histol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"100618","DOI":"10.1016\/j.cpcardiol.2020.100618","article-title":"COVID-19 and multiorgan response","volume":"45","author":"Zaim","year":"2020","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e1453","DOI":"10.1016\/S2214-109X(20)30444-7","article-title":"COVID-19 pneumonia and the appropriate use of antibiotics","volume":"8","author":"Ginsburg","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41564-019-0357-1","article-title":"Drug repurposing for antimicrobial discovery","volume":"4","author":"Farha","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.2174\/0929867323666160411142532","article-title":"Diaryl urea: A privileged structure in anticancer agents","volume":"23","author":"Garuti","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Catalano, A., Iacopetta, D., Sinicropi, M.S., and Franchini, C. (2021). Diarylureas as antitumor agents. Appl. Sci., 11.","DOI":"10.3390\/app11010374"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4172\/2161-0444.1000305","article-title":"Role of Aryl Urea Containing Compounds in Medicinal Chemistry","volume":"5","author":"Sikka","year":"2015","journal-title":"Med. Chem."},{"key":"ref_17","first-page":"38","article-title":"Short notes on diaryl ureas derivatives","volume":"1","author":"Asif","year":"2018","journal-title":"J. Adv. Res. Biochem. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/bs.armc.2019.06.002","article-title":"Dealing with schistosomiasis: Current drug discovery strategies","volume":"Volume 53","author":"Gemma","year":"2019","journal-title":"Annual Reports in Medicinal Chemistry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bmcl.2017.12.064","article-title":"Progress in antischistosomal N,N\u2032-diaryl urea SAR","volume":"28","author":"Wu","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ml100083c","article-title":"Evaluation of diarylureas for activity against Plasmodium falciparum","volume":"1","author":"Zhang","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.1021\/jm5006226","article-title":"Discovery of 4-aryl-7-hydroxyindoline-based P2Y1 antagonists as novel antiplatelet agents","volume":"57","author":"Yang","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejmech.2019.05.010","article-title":"Recent update on anti-dengue drug discovery","volume":"176","author":"Dighe","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1021\/acs.jmedchem.7b00707","article-title":"Novel diarylurea based allosteric modulators of the cannabinoid CB1 receptor: Evaluation of importance of 6-pyrrolidinylpyridinyl substitution","volume":"60","author":"Nguyen","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.1016\/j.bmcl.2006.08.044","article-title":"Pyridone derivatives as potent, orally bioavailable VLA-4 integrin antagonists","volume":"16","author":"Witherington","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Jiang, N., Bu, Y., Wang, Y., Nie, M., Zhang, D., and Zhai, X. (2016). Design, Synthesis and Structure\u2013Activity Relationships of Novel Diaryl Urea Derivatives as Potential EGFR Inhibitors. Molecules, 21.","DOI":"10.3390\/molecules21111572"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/2666796701999200617154655","article-title":"COVID-19: Could Irisin Become the Handyman Myokine of the 21st Century?","volume":"1","author":"Catalano","year":"2020","journal-title":"Coronaviruses"},{"key":"ref_27","first-page":"100434","article-title":"Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series","volume":"24","author":"Rapkiewicz","year":"2020","journal-title":"E Clin. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbi.2020.07.037","article-title":"Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors","volume":"89","author":"Mazza","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Phillips, N., Park, I.-W., Robinson, J.R., and Jones, H.P. (2020). The perfect storm: COVID-19 health disparities in US blacks. J. Racial Ethn. Health Disparities, 1\u20138.","DOI":"10.1007\/s40615-020-00871-y"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Patini, R., Mangino, G., Martellacci, L., Quaranta, G., Masucci, L., and Gallenzi, P. (2020). The effect of different antibiotic regimens on bacterial resistance: A systematic review. Antibiotics, 9.","DOI":"10.3390\/antibiotics9010022"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ecoenv.2016.11.014","article-title":"A review of the occurrence of pharmaceuticals and personal care products in Indian water bodies","volume":"137","author":"Balakrishna","year":"2017","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Bergman, \u00c5., Heindel, J.J., Jobling, S., Kidd, K.A., and Zoeller, R.T. (2013). The State-of-the-Science of Endocrine Disrupting Chemicals, World Health Organization and United Nations Environment Programme Report\u20132012, UNEP\/WHO. Available online: www.who.int\/ceh\/publications\/endocrine\/en\/index.html.","DOI":"10.1016\/j.toxlet.2012.03.020"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.taap.2011.06.017","article-title":"Inhibition of soluble epoxide hydrolase contributes to the anti-inflammatory effect of antimicrobial triclocarban in a murine model","volume":"255","author":"Liu","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1021\/acs.jafc.7b05220","article-title":"Metabonomics indicates inhibition of fatty acid synthesis, beta-oxidation, and tricarboxylic acid cycle in triclocarban-induced cardiac metabolic alterations in male mice","volume":"66","author":"Xie","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jhazmat.2016.03.028","article-title":"Association of birth outcomes with fetal exposure to parabens, triclosan and triclocarban in an immigrant population in Brooklyn, New York","volume":"323","author":"Geer","year":"2017","journal-title":"J. Hazard. Mater."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"111237","DOI":"10.1016\/j.jenvman.2020.111237","article-title":"The fate of triclocarban in activated sludge and its influence on biological wastewater treatment system","volume":"276","author":"Wang","year":"2020","journal-title":"J. Environ. Manag."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"121944","DOI":"10.1016\/j.jhazmat.2019.121944","article-title":"Fate, risk and removal of triclocarban: A critical review","volume":"387","author":"Yun","year":"2020","journal-title":"J. Hazard. Mater."},{"key":"ref_38","first-page":"135","article-title":"Medicinal chemistry of ureido derivatives as anti-infectives","volume":"5","author":"Batra","year":"2006","journal-title":"Anti-Infect. Agents Med. Chem. (Former Curr. Med. Chem. Anti-Infect. Agents)"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Macsics, R., Hackl, M.W., Fetzer, C., Mostert, D., Bender, J., Layer, F., and Sieber, S.A. (2020). Comparative Target Analysis of Chlorinated Biphenyl Antimicrobials Highlights MenG as Molecular Target of Triclocarban. Appl. Environ. Microbiol.","DOI":"10.1128\/AEM.00933-20"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-018-0013-8","article-title":"Schistosomiasis","volume":"4","author":"McManus","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Herricks, J.R., Hotez, P.J., Wanga, V., Coffeng, L.E., Haagsma, J.A., Basanez, M.G., Buckle, G., Budke, C.M., Carabin, H., and Fevre, E.M. (2017). The global burden of disease study 2013: What does it mean for the NTDs?. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005424"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4269\/ajtmh.19-0825","article-title":"SCORE operational research on moving toward interruption of schistosomiasis transmission","volume":"103","author":"Campbell","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00281-020-00789-x","article-title":"Schistosomiasis-from immunopathology to vaccines","volume":"42","author":"McManus","year":"2020","journal-title":"Semin. Immunopathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1002\/cmdc.201800572","article-title":"Chemotherapy for fighting schistosomiasis: Past, present and future","volume":"13","author":"Rennar","year":"2018","journal-title":"ChemMedChem"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"McManus, D.P. (2020). Recent progress in the development of liver fluke and blood fluke vaccines. Vaccines, 8.","DOI":"10.3390\/vaccines8030553"},{"key":"ref_46","unstructured":"Dang, N.L., Hughes, T.B., and Taramelli, D. (2016). Open source drug discovery with the Malaria Box compound collection for neglected diseases and beyond. PLoS Pathog., 12."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Ingram-Sieber, K., Cowan, N., Panic, G., Vargas, M., Mansour, N.R., Bickle, Q.D., Wells, T.N.C., Spangenberg, T., and Keiser, J. (2014). Orally active antischistosomal early leads identified from the open access Malaria Box. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0002610"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1128\/AAC.04463-14","article-title":"Activities of N,N\u2019-diarylurea MMV665852 analogs against Schistosoma mansoni","volume":"59","author":"Cowan","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.bmcl.2016.01.075","article-title":"Antischistosomal activity of N,N\u2032-arylurea analogs against Schistosoma japonicum","volume":"26","author":"Yao","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_50","unstructured":"Cole, S., Codling, I.D., Parr, W., and Zabel, T. (1999). Guidelines for Managing Water Quality Impacts within UK European Marine Sites, WRc Swindon Frankland Road Blagrove Swindon. UK Marine SACs Project."},{"key":"ref_51","unstructured":"Tomlin CDS (1995). The Pesticide Manua, British Crop Protection Council. [10th ed.]."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1021\/acs.est.9b07390","article-title":"Multiple bioassays and targeted and nontargeted analyses to characterize potential toxicological effects associated with sediments of masan bay: Focusing on AhR-mediated potency","volume":"54","author":"Lee","year":"2020","journal-title":"Environ. Sci. Technol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"140181","DOI":"10.1016\/j.scitotenv.2020.140181","article-title":"Target and suspect screening analysis reveals persistent emerging organic contaminants in soils and sediments","volume":"740","author":"Scheringer","year":"2020","journal-title":"Sci. Total Environ."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s13071-015-1023-y","article-title":"Repurposing of anticancer drugs: In vitro and in vivo activities against Schistosoma mansoni","volume":"8","author":"Cowan","year":"2015","journal-title":"Parasite Vect."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Pujol, E., Blanco-Cabra, N., Juli\u00e1n, E., Leiva, R., Torrents, E., and V\u00e1zquez, S. (2018). Pentafluorosulfanyl-containing triclocarban analogs with potent antimicrobial activity. Molecules, 23.","DOI":"10.3390\/molecules23112853"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41557-019-0378-7","article-title":"Repurposing human kinase inhibitors to create an antibiotic active against drug-resistant Staphylococcus aureus, persisters and biofilms","volume":"12","author":"Le","year":"2020","journal-title":"Nat. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1002\/jcp.25014","article-title":"GRP78\/Dna K is a target for Nexavar\/Stivarga\/Votrient in the treatment of human malignancies, viral infections and bacterial diseases","volume":"230","author":"Roberts","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/jac\/dkv367","article-title":"In vitro and in vivo activity of a novel sorafenib derivative SC5005 against MRSA","volume":"71","author":"Chang","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bmcl.2003.09.082","article-title":"Phenyl thiazolyl urea and carbamate derivatives as new inhibitors of bacterial cell-wall biosynthesis","volume":"14","author":"Francisco","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"100276","DOI":"10.1016\/j.cdc.2019.100276","article-title":"Virtual screening approach and biochemical evaluation on MurB","volume":"24","author":"Hrast","year":"2019","journal-title":"Chem. Data Collect."},{"key":"ref_61","first-page":"1","article-title":"A convenient synthesis of some diarylurea and thiourea derivatives as antimicrobial compounds","volume":"25","author":"Hassan","year":"2014","journal-title":"Chem. Process Eng. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/mBio.01140-20","article-title":"The neutrally charged diarylurea compound PQ401 kills antibiotic-resistant and antibiotic-tolerant Staphylococcus aureus","volume":"11","author":"Kim","year":"2020","journal-title":"mBio"},{"key":"ref_63","first-page":"997","article-title":"A Facile Synthesis of diaylureas and their antimicrobial evaluation","volume":"45","author":"Sarveswari","year":"2018","journal-title":"Chiang Mai J. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1107\/S0907444912026236","article-title":"The structure of Enterococcus faecalis thymidylate synthase provides clues about folate bacterial metabolism","volume":"68","author":"Pozzi","year":"2012","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e1700223","DOI":"10.1002\/cbdv.201700223","article-title":"Synthesis and Biological Evaluation of Novel 1-(4-(Hydroxy(1-oxo-1,3-dihydro-2H-inden-2-ylidene)methyl)phenyl)-3-phenylurea Derivatives","volume":"14","author":"Gezegen","year":"2017","journal-title":"Chem. Biodivers."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Ceramella, J., Mariconda, A., Rosano, C., Iacopetta, D., Caruso, A., Longo, P., Sinicropi, M.S., and Saturnino, C. (2020). \u03b1\u2013\u03c9 Alkenyl-bis-S-guanidine thiourea dihydrobromide affects HeLa cell growth hampering tubulin polymerization. ChemMedChem, in press.","DOI":"10.1002\/cmdc.202000544"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejmech.2017.02.044","article-title":"Diphenylurea derivatives for combating methicillin- and vancomycin-resistant Staphylococcus aureus","volume":"130","author":"Eissa","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Mohammad, H., Younis, W., Ezzat, H.G., Peters, C.E., AbdelKhalek, A., Cooper, B., Pogliano, K., Pogliano, J., Mayhoub, A.S., and Seleem, M.N. (2017). Bacteriological profiling of diphenylureas as a novel class of antibiotics against methicillin-resistant Staphylococcus aureus. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0182821"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1016\/j.bmc.2009.04.069","article-title":"Chattapadhayaya, Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis","volume":"17","author":"Upadhayaya","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ejmech.2016.09.083","article-title":"Attenuation of Mycobacterium species through direct and macrophage mediated pathway by unsymmetrical diaryl urea","volume":"125","author":"Velappan","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.3390\/molecules18033562","article-title":"Synthesis and biological activity of substituted urea and thiourea derivatives containing 1,2,4-triazole moieties","volume":"18","author":"Celen","year":"2013","journal-title":"Molecules"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Caruso, A., Ceramella, J., Iacopetta, D., Saturnino, C., Mauro, M.V., Bruno, R., Aquaro, S., and Sinicropi, M.S. (2019). Carbazole Derivatives as Antiviral Agents: An Overview. Molecules, 24.","DOI":"10.3390\/molecules24101912"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.bmcl.2017.12.019","article-title":"Identification of novel small-molecule inhibitors of Zika virus infection","volume":"28","author":"Micewicz","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"126626","DOI":"10.1016\/j.bmcl.2019.126626","article-title":"Optimization of 1, 3-disubstituted urea-based inhibitors of Zika virus infection","volume":"29","author":"Khachatoorian","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ejmech.2016.10.007","article-title":"Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design","volume":"125","author":"Benmansour","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1128\/AAC.45.9.2577-2584.2001","article-title":"New class of small non peptidyl compounds blocks plasmodium falciparum development in vitro by inhibiting plasmepsins","volume":"45","author":"Jiang","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.bmcl.2012.12.022","article-title":"Novel diaryl ureas with efficacy in a mouse model of malaria","volume":"23","author":"Anderson","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_78","first-page":"157","article-title":"Novel, selective \u03946 or \u03945 fatty acid desaturase inhibitors as antiinflammatory agents in mice","volume":"287","author":"Obukowicz","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1021\/acsmedchemlett.6b00241","article-title":"T-3364366 targets the desaturase domain of delta-5 desaturase with nanomolar potency and a multihour residence time","volume":"7","author":"Miyahisa","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1016\/j.bmcl.2012.08.118","article-title":"Synthesis, anti-inflammatory and antimicrobial evaluation of novel 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazole derivatives bearing urea, thiourea and sulfonamide moieties","volume":"22","author":"Keche","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s00044-017-1878-x","article-title":"Synthesis and SAR studies of potent H+\/K+-ATPase and anti-inflammatory activities of symmetrical and unsymmetrical urea analogues","volume":"26","author":"Rakesh","year":"2017","journal-title":"Med. Chem. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-48538-x","article-title":"Blockade of \u03b14 integrins reduces leukocyte\u2013endothelial interactions in cerebral vessels and improves memory in a mouse model of Alzheimer\u2019s disease","volume":"9","author":"Pietronigro","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/crj.12277","article-title":"Up-regulated integrin\u03b14\u03b21 on systemic lymphocytes and serum IL-17 A in interstitial pneumonia","volume":"10","author":"Taooka","year":"2016","journal-title":"Clin. Respir. J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/1744666X.2020.1803064","article-title":"Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia","volume":"16","author":"Manfredi","year":"2020","journal-title":"Exp. Rev. Clin. Immunol."},{"key":"ref_85","unstructured":"Astles, P.C., Clark, D.E., Collis, A.J., Cox, P.J., Eastwood, P.R., Harris, N.V., Lai, J.Y.Q., Morley, A.D., and Porter, B. (2002). Substituted Anilines. (6,479,519), U.S. Patent."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.bmcl.2006.01.025","article-title":"Pyridone derivatives as potent and selective VLA-4 integrin antagonists","volume":"16","author":"Witherington","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000481824","article-title":"Immunoregulatory role of cannabinoids during infectious disease","volume":"24","year":"2017","journal-title":"Neuroimmunomodulation"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.bjp.0707347","article-title":"PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats","volume":"152","author":"Horswill","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1021\/acs.jmedchem.6b01448","article-title":"Pyrimidinyl biphenylureas: Identification of new lead compounds as allosteric modulators of the cannabinoid receptor CB1","volume":"60","author":"Khurana","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"100574","DOI":"10.1016\/j.curtheres.2019.100574","article-title":"Structural optimization of the diarylurea PSNCBAM-1, an allosteric modulator of Cannabinoid receptor 1","volume":"92","author":"Dopart","year":"2020","journal-title":"Curr. Ther. Res."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Sriram, K., and Insel, P.A. (2020). Inflammation and thrombosis in COVID-19 pathophysiology: Proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets. Physiol. Rev.","DOI":"10.1152\/physrev.00035.2020"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1021\/jm301708u","article-title":"Discovery of 2-(phenoxyaryl)-3-phenylureas as small molecule P2Y1 antagonists","volume":"56","author":"Chao","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature14287","article-title":"Two disparate ligand-binding sites in the human P2Y1 receptor","volume":"520","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1016\/j.bmcl.2013.03.125","article-title":"Discovery of diarylurea P2Y1 antagonists with improved aqueous solubility","volume":"23","author":"Wang","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejmech.2018.09.014","article-title":"Design, synthesis, and biological evaluation of 2-(phenoxyaryl)-3-urea derivatives as novel P2Y1 receptor antagonists","volume":"158","author":"Peng","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"9275","DOI":"10.1021\/jm4013906","article-title":"Conformationally constrained orthoanilino diaryl ureas, discovery of 1-(2-(10-neopentylspiro[indoline-3,40-piperidine]-1-yl)phenyl)-3-(4-(trifluoro-methoxy) phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonist","volume":"56","author":"Qiao","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.bmcl.2014.01.066","article-title":"Identification of 1-{2-[4-chloro-1\u2032-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4\u2032-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo [5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y1 antagonist as an antiplatelet agent","volume":"24","author":"Jeon","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/cmdc.201402141","article-title":"4-Benzothiazole-7-hydroxyindolinyl diaryl ureas are potent P2Y1 antagonists with favorable pharmacokinetics: Low clearance and small volume of distribution","volume":"9","author":"Qiao","year":"2014","journal-title":"ChemMedChem"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s12272-016-0720-1","article-title":"Design and synthesis of some new 1-phenyl-3\/4-[4-(aryl\/heteroaryl\/alkyl-piperazine1-yl)-phenyl-ureas as potent anticonvulsant and antidepressant agents","volume":"39","author":"Mishra","year":"2016","journal-title":"Arch. Pharmacal Res."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Carnevale, V., and Rohacs, T. (2016). TRPV1: A target for rational drug design. Pharmaceuticals, 9.","DOI":"10.3390\/ph9030052"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1208\/s12248-016-9888-z","article-title":"Multi-functional diarylurea small molecule inhibitors of TRPV1 with therapeutic potential for neuroinflammation","volume":"18","author":"Feng","year":"2016","journal-title":"AAPS J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejmech.2015.07.005","article-title":"Potential of aryl\u2013urea\u2013benzofuranylthiazoles hybrids as multitasking agents in Alzheimer\u2019s disease","volume":"102","author":"Kurt","year":"2015","journal-title":"Eur. J. Med. Chem."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/10\/1\/92\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:12:46Z","timestamp":1760159566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/10\/1\/92"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["antibiotics10010092"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics10010092","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]}}}